137 related articles for article (PubMed ID: 24443255)
1. Clinical significance and biological roles of CARMA3 in human bladder carcinoma.
Man X; He J; Kong C; Zhu Y; Zhang Z
Tumour Biol; 2014 May; 35(5):4131-6. PubMed ID: 24443255
[TBL] [Abstract][Full Text] [Related]
2. CARMA3 is upregulated in human pancreatic carcinoma, and its depletion inhibits tumor proliferation, migration, and invasion.
Du S; Jia L; Zhang Y; Fang L; Zhang X; Fan Y
Tumour Biol; 2014 Jun; 35(6):5965-70. PubMed ID: 24633921
[TBL] [Abstract][Full Text] [Related]
3. CARMA3 is overexpressed in colon cancer and regulates NF-κB activity and cyclin D1 expression.
Miao Z; Zhao T; Wang Z; Xu Y; Song Y; Wu J; Xu H
Biochem Biophys Res Commun; 2012 Sep; 425(4):781-7. PubMed ID: 22884800
[TBL] [Abstract][Full Text] [Related]
4. CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-κB regulation in breast cancer cells.
Zhao T; Miao Z; Wang Z; Xu Y; Wu J; Liu X; You Y; Li J
Tumour Biol; 2013 Oct; 34(5):3041-7. PubMed ID: 23708960
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CARMA3 is associated with advanced tumor stage, cell cycle progression, and cisplatin resistance in human epithelial ovarian cancer.
Xie C; Han Y; Fu L; Li Q; Qiu X; Wang E
Tumour Biol; 2014 Aug; 35(8):7957-64. PubMed ID: 24833094
[TBL] [Abstract][Full Text] [Related]
6. CARMA3 is overexpressed in human glioma and promotes cell invasion through MMP9 regulation in A172 cell line.
Feng X; Miao G; Han Y; Xu Y
Tumour Biol; 2014 Jan; 35(1):149-54. PubMed ID: 23893382
[TBL] [Abstract][Full Text] [Related]
7. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
Tan ST; Liu SY; Wu B
Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance and biological roles of CRKL in human bladder carcinoma.
Han B; Luan L; Xu Z; Wu B
Tumour Biol; 2014 May; 35(5):4101-6. PubMed ID: 24375195
[TBL] [Abstract][Full Text] [Related]
9. Rab11 Functions as an Oncoprotein via Nuclear Factor kappa B (NF-κB) Signaling Pathway in Human Bladder Carcinoma.
Gong X; Liu J; Zhang X; Dong F; Liu Y; Wang P
Med Sci Monit; 2018 Jul; 24():5093-5101. PubMed ID: 30032159
[TBL] [Abstract][Full Text] [Related]
10. CARMA3/NF-κB signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate.
Hou H; Li WX; Cui X; Zhou DC; Zhang B; Geng XP
World J Gastroenterol; 2019 Sep; 25(36):5483-5493. PubMed ID: 31576094
[TBL] [Abstract][Full Text] [Related]
11. Expression and biological roles of SATB1 in human bladder cancer.
Han B; Luan L; Xu Z; Wu B
Tumour Biol; 2013 Oct; 34(5):2943-9. PubMed ID: 23696028
[TBL] [Abstract][Full Text] [Related]
12. Rab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasion.
Jiang Y; Han Y; Sun C; Han C; Han N; Zhi W; Qiao Q
Tumour Biol; 2016 Jun; 37(6):8131-8. PubMed ID: 26715272
[TBL] [Abstract][Full Text] [Related]
13. CARMA3 Represses Metastasis Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis.
Chang YW; Chiu CF; Lee KY; Hong CC; Wang YY; Cheng CC; Jan YH; Huang MS; Hsiao M; Ma JT; Su JL
Am J Respir Crit Care Med; 2015 Jul; 192(1):64-75. PubMed ID: 25906011
[TBL] [Abstract][Full Text] [Related]
14. Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.
Tang ZP; Dong QZ; Cui QZ; Papavassiliou P; Wang ED; Wang EH
PLoS One; 2013; 8(6):e63676. PubMed ID: 23776433
[TBL] [Abstract][Full Text] [Related]
15. The circINTS4/miR-146b/CARMA3 axis promotes tumorigenesis in bladder cancer.
Zhang X; Liu X; Jing Z; Bi J; Li Z; Liu X; Li J; Li Z; Zhang Z; Kong C
Cancer Gene Ther; 2020 Apr; 27(3-4):189-202. PubMed ID: 30723269
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
Mahanivong C; Chen HM; Yee SW; Pan ZK; Dong Z; Huang S
Oncogene; 2008 Feb; 27(9):1273-80. PubMed ID: 17724468
[TBL] [Abstract][Full Text] [Related]
17. CARMA3: Scaffold Protein Involved in NF-κB Signaling.
Zhang S; Lin X
Front Immunol; 2019; 10():176. PubMed ID: 30814996
[TBL] [Abstract][Full Text] [Related]
18. CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.
Jiang T; Grabiner B; Zhu Y; Jiang C; Li H; You Y; Lang J; Hung MC; Lin X
Cancer Res; 2011 Mar; 71(6):2183-92. PubMed ID: 21406399
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progression.
Li Z; Qu L; Dong Q; Huang B; Li H; Tang Z; Xu Y; Luo W; Liu L; Qiu X; Wang E
PLoS One; 2012; 7(5):e36903. PubMed ID: 22615840
[TBL] [Abstract][Full Text] [Related]
20. CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex.
Rehman AO; Wang CY
Int J Oral Sci; 2009 Sep; 1(3):105-18. PubMed ID: 20695076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
